GeneTex
  • Country / Location Selection

United States (US)

MLL2 blocking peptide

Cat. No. GTX15962-PEP

Species

Human
Package
100 μg ($239)

APPLICATION

Product Note

The peptide was used in the production of GTX15962.

PROPERTIES

Form

Lyophilized powder

Buffer

Reconstitute with 200μl distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O.

Preservative

No preservative

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

DSQNLAGEDKDSQ-C

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Lysine Methyltransferase 2D , Aad10 , Alr , Cagl114 , Kabuk1 , Kms , Mll2 , Mll4 , Tnrc21 , Kmt2D

Background

The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]

Research Area

REFERENCE

There are currently no references for MLL2 blocking peptide (GTX15962-PEP). Be the first to share your publications with this product.

REVIEW

There are currently no reviews for MLL2 blocking peptide (GTX15962-PEP). Be the first to share your experience with this product.
Package List Price ($)
$ 239